Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 4/20 | 0.65 |
| ▸ | MAOB | P27338 | 5/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2519025 | 1.00 | GRM5 (0.65) | GRM5MAOBMAOAGRM2 | |
| SCHEMBL15856164 | 0.86 | GRM5 (0.50) | GRM5GRM2 | |
| SCHEMBL7811161 | 0.86 | GRM5 (0.50) | GRM5GRM2 | |
| SCHEMBL17286803 | 0.86 | GRM5 (0.48) | GRM5MAOBMAOAGRM2 | |
| SCHEMBL17286801 | 0.86 | GRM5 (0.48) | GRM5MAOBMAOAGRM2 | |
| SCHEMBL3327072 | 0.84 | MAOA (0.47) | GRM5MAOBMAOA | |
| SCHEMBL15856197 | 0.84 | MAOA (0.47) | GRM5MAOBMAOA | |
| SCHEMBL15856168 | 0.84 | MAOA (0.47) | GRM5MAOBMAOA | |
| SCHEMBL3325784 | 0.83 | GRM5 (0.46) | GRM5GRM2 | |
| SCHEMBL15856178 | 0.83 | GRM5 (0.46) | GRM5MAOBMAOAGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0657440-B1 | Oxazolidine-2-one derivatives as MAO inhibitors | HOFFMANN LA ROCHE (CH) | 2000-04-05 | — | — | EP | disclosed |
| US-5574055-A | COGNITIVE AND NEURODEGENERATIVE DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0657440-A1 | Oxazolidine-2-one derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1995-06-14 | — | — | EP | disclosed |